Healthcare / Medical: Diagnostics & Research
Illumina, Inc.ILMN
Illumina sells DNA sequencers, led by the NovaSeq X, and the consumables (flow cells and reagents) each run uses, plus microarrays, services and analysis software.
- Edition
- Nov 11, 2026
- Covers
- Q3 2026
- Length
- 7 pages
In This Report
- 1SummaryThe takeaway, the case for and what could go wrong
- 2Financial HealthSales, margins, cash flow and debt over the years
- 3Business TrendsThe segments and the operating numbers the company reports
- 4Capital AllocationBuybacks, the share count and where the cash goes
- 5ValuationThe price against the stock's own history and the intrinsic value models
- 6Outlook and RisksAnalyst estimates, guidance and the risks to watch
- 7MethodologyGlossary, sources and disclosures